Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

ICN expands Kinerase license with Senetek

Aug. 20, 2003

Arriva-ProMetic completes phase I trial of rAAT in atopic dermatitis patients

Aug. 19, 2003

Galderma presents new PPARgamma agonists with potential in dermatological disorders

Aug. 12, 2003

Pivotal phase III trial for Cellegesic makes solid progress

Aug. 11, 2003

Astralis cleared to begin phase I testing of Psoraxine in U.S.

Aug. 6, 2003

Durable remission following treatment with i.m. alefacept in chronic plaque psoriasis

July 30, 2003

New phase II study evaluates COL-3 in rosacea

July 29, 2003

Effective treatment of chronic anal fissures reported with topical nifedipine

July 18, 2003

Pivotal European study of Adhibit commences enrollment

July 17, 2003

Noncalcemic vitamin D analogue designed by Wisconsin researchers

July 17, 2003

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....